Quince Therapeutics Inc.
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 41 institutions reported holding Quince Therapeutics Inc. in their 13F filings, up 5 from Q1 2025. 10 opened new positions and 5 sold out. The largest holders were Nantahala Capital Management, LLC ($4.2M), Vanguard Group Inc. ($2.4M) and Ieq Capital, LLC ($725K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Quince Therapeutics Inc.
- CUSIP
- 22053A107
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $4.9M |
| Exits | 5 | $323K |
All 13F filers, Q1 2025 → Q2 2025: 3,233,805 shares bought and 885,278 shares sold, net +2,348,527 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 41 holders
| Nantahala Capital Management, LLC | 0.30% | New | 2,528,302 | $4.2M |
| Vanguard Group Inc. | 0.00% | Add +13.1% | 1,454,038 | $2.4M |
| Ieq Capital, LLC | 0.00% | Reduce -45.5% | 439,270 | $725K |
| Geode Capital Management, LLC | 0.00% | Add +0.3% | 396,982 | $655K |
| Renaissance Technologies | 0.00% | Reduce -24.0% | 379,800 | $627K |
| BlackRock, Inc. | 0.00% | Reduce -2.8% | 335,738 | $554K |
| HighTower Advisors, LLC | 0.00% | Reduce -10.2% | 308,500 | $509K |
| Alphabet Inc. | 0.01% | No change | 189,122 | $312K |
| Rockefeller Capital Management L.P. | 0.00% | New | 169,554 | $280K |
| Shay Capital LLC | 0.06% | Reduce -18.6% | 150,000 | $248K |
| ADAR1 Capital Management, LLC | 0.04% | No change | 142,958 | $236K |
| Bridgeway Capital Management, LLC | 0.01% | Add +20.9% | 128,617 | $212K |
| State Street Corp. | 0.00% | No change | 124,911 | $206K |
| Mariner, LLC | 0.00% | No change | 122,461 | $202K |
| Union Square Park Capital Management, LLC | 0.18% | New | 120,857 | $199K |
| Millennium Management | 0.00% | New | 110,682 | $183K |
| Citadel Advisors | 0.00% | Add +132.5% | 93,905 | $155K |
| Scharf Investments, LLC | 0.00% | No change | 91,061 | $150K |
| Northern Trust Corp. | 0.00% | No change | 77,492 | $128K |
| Intellectus Partners, LLC | 0.02% | No change | 53,312 | $88K |
| Gsa Capital Partners LLP | 0.00% | Reduce -7.7% | 33,818 | $56K |
| Anfield Capital Management, LLC | 0.02% | No change | 30,227 | $50K |
| XTX Topco Ltd | 0.00% | New | 22,660 | $37K |
| Two Sigma Investments, LP | 0.00% | Reduce -57.8% | 17,386 | $29K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 15,200 | $25K |
| Two Sigma Securities, LLC | 0.00% | New | 12,004 | $20K |
| Nixon Peabody Trust Co. | 0.00% | No change | 11,126 | $18K |
| Wells Fargo & Company | 0.00% | New | 6,990 | $12K |
| Morgan Stanley | 0.00% | Reduce -92.0% | 4,302 | $7K |
| Bank of America Corp. | 0.00% | Add +2.1% | 2,904 | $5K |
| UBS Group AG | 0.00% | Add +303.1% | 2,846 | $5K |
| JPMorgan Chase & Co. | 0.00% | Reduce -14.3% | 469 | $774 |
| JDM Financial Group LLC | 0.00% | No change | 340 | $561 |
| Parallel Advisors, LLC | 0.00% | No change | 295 | $487 |
| Osaic Holdings, Inc. | 0.00% | No change | 277 | $457 |
| Hurley Capital, LLC | 0.00% | No change | 121 | $200 |
| Harbour Investments, Inc. | 0.00% | New | 100 | $165 |
| SBI Securities Co., Ltd. | 0.00% | Add +4.0% | 77 | $127 |
| Westside Investment Management, Inc. | 0.00% | No change | 75 | $124 |
| Barclays PLC | 0.00% | No change | 23 | $38 |
| BNP Paribas Financial Markets | 0.00% | New | 8 | $13 |
"% of holder's portfolio" is QUINCE THERAPEUTICS INC's weight in each manager's 13F, not the share of Quince Therapeutics Inc. the manager owns.